$FOLD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMICUS THERAPEUTICS, INC.. Get notifications about new insider transactions in AMICUS THERAPEUTICS, INC. for free.
Page: < prev 1 ... 12 13 14 15 16 17 18 19 20 ... 28 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.90 | 408 | 4,039 | 834,966 | 834.6 K to 835 K (+0.05 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.88 | 140 | 1,383 | 834,558 | 834.4 K to 834.6 K (+0.02 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.87 | 100 | 987 | 834,418 | 834.3 K to 834.4 K (+0.01 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.86 | 100 | 986 | 834,318 | 834.2 K to 834.3 K (+0.01 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.85 | 200 | 1,970 | 834,218 | 834 K to 834.2 K (+0.02 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.84 | 100 | 984 | 834,018 | 833.9 K to 834 K (+0.01 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.79 | 100 | 979 | 833,918 | 833.8 K to 833.9 K (+0.01 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.75 | 200 | 1,950 | 833,818 | 833.6 K to 833.8 K (+0.02 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.74 | 2,500 | 24,350 | 833,618 | 831.1 K to 833.6 K (+0.30 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.72 | 100 | 972 | 831,118 | 831 K to 831.1 K (+0.01 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.69 | 200 | 1,938 | 831,018 | 830.8 K to 831 K (+0.02 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.68 | 100 | 968 | 830,818 | 830.7 K to 830.8 K (+0.01 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.67 | 400 | 3,868 | 830,718 | 830.3 K to 830.7 K (+0.05 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.66 | 400 | 3,864 | 830,318 | 829.9 K to 830.3 K (+0.05 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.63 | 200 | 1,926 | 829,918 | 829.7 K to 829.9 K (+0.02 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.60 | 200 | 1,920 | 829,718 | 829.5 K to 829.7 K (+0.02 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 10.00 | 4,497 | 44,970 | 829,518 | 825 K to 829.5 K (+0.55 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.99 | 900 | 8,991 | 825,021 | 824.1 K to 825 K (+0.11 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.98 | 303 | 3,024 | 824,121 | 823.8 K to 824.1 K (+0.04 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.97 | 100 | 997 | 823,818 | 823.7 K to 823.8 K (+0.01 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.96 | 600 | 5,976 | 823,718 | 823.1 K to 823.7 K (+0.07 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.95 | 676 | 6,726 | 823,118 | 822.4 K to 823.1 K (+0.08 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.94 | 300 | 2,982 | 822,442 | 822.1 K to 822.4 K (+0.04 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.93 | 1,400 | 13,902 | 822,142 | 820.7 K to 822.1 K (+0.17 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.92 | 100 | 992 | 820,742 | 820.6 K to 820.7 K (+0.01 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.91 | 500 | 4,955 | 820,642 | 820.1 K to 820.6 K (+0.06 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.90 | 400 | 3,960 | 820,142 | 819.7 K to 820.1 K (+0.05 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.89 | 1,240 | 12,264 | 819,742 | 818.5 K to 819.7 K (+0.15 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.88 | 100 | 988 | 818,502 | 818.4 K to 818.5 K (+0.01 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.87 | 413 | 4,076 | 818,402 | 818 K to 818.4 K (+0.05 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.86 | 986 | 9,722 | 817,989 | 817 K to 818 K (+0.12 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.85 | 2,514 | 24,763 | 817,003 | 814.5 K to 817 K (+0.31 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.84 | 697 | 6,858 | 814,489 | 813.8 K to 814.5 K (+0.09 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.83 | 200 | 1,966 | 813,792 | 813.6 K to 813.8 K (+0.02 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9,825.00 | 2,500 | 24,562,500 | 813,592 | 811.1 K to 813.6 K (+0.31 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.82 | 500 | 4,911 | 811,092 | 810.6 K to 811.1 K (+0.06 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.82 | 700 | 6,874 | 810,592 | 809.9 K to 810.6 K (+0.09 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.81 | 300 | 2,943 | 809,892 | 809.6 K to 809.9 K (+0.04 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.80 | 600 | 5,880 | 809,592 | 809 K to 809.6 K (+0.07 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.79 | 500 | 4,896 | 808,992 | 808.5 K to 809 K (+0.06 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.78 | 6,024 | 58,915 | 808,492 | 802.5 K to 808.5 K (+0.75 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.77 | 300 | 2,931 | 802,468 | 802.2 K to 802.5 K (+0.04 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.76 | 2,873 | 28,040 | 802,168 | 799.3 K to 802.2 K (+0.36 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.75 | 577 | 5,626 | 799,295 | 798.7 K to 799.3 K (+0.07 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.74 | 600 | 5,844 | 798,718 | 798.1 K to 798.7 K (+0.08 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.73 | 100 | 973 | 798,118 | 798 K to 798.1 K (+0.01 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.72 | 2,900 | 28,188 | 798,018 | 795.1 K to 798 K (+0.36 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.71 | 400 | 3,884 | 795,118 | 794.7 K to 795.1 K (+0.05 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.70 | 300 | 2,910 | 794,718 | 794.4 K to 794.7 K (+0.04 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.69 | 1,400 | 13,566 | 794,418 | 793 K to 794.4 K (+0.18 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.68 | 400 | 3,872 | 793,018 | 792.6 K to 793 K (+0.05 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.65 | 1,600 | 15,440 | 792,618 | 791 K to 792.6 K (+0.20 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.65 | 300 | 2,894 | 791,018 | 790.7 K to 791 K (+0.04 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.64 | 1,200 | 11,568 | 790,718 | 789.5 K to 790.7 K (+0.15 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.64 | 100 | 964 | 789,518 | 789.4 K to 789.5 K (+0.01 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.63 | 300 | 2,889 | 789,418 | 789.1 K to 789.4 K (+0.04 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.61 | 500 | 4,805 | 789,118 | 788.6 K to 789.1 K (+0.06 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.61 | 100 | 961 | 788,618 | 788.5 K to 788.6 K (+0.01 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.60 | 11,800 | 113,280 | 788,518 | 776.7 K to 788.5 K (+1.52 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.60 | 3,800 | 36,471 | 776,718 | 772.9 K to 776.7 K (+0.49 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.59 | 3,200 | 30,688 | 772,918 | 769.7 K to 772.9 K (+0.42 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.58 | 1,800 | 17,244 | 769,718 | 767.9 K to 769.7 K (+0.23 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.57 | 300 | 2,870 | 767,918 | 767.6 K to 767.9 K (+0.04 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.54 | 100 | 954 | 767,618 | 767.5 K to 767.6 K (+0.01 %) |
Mar 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.51 | 100 | 951 | 767,518 | 767.4 K to 767.5 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Option Exercise | M | 0.64 | 10,000 | 6,380 | 79,930 | |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.00 | 4,497 | 44,970 | 58,836 | 63.3 K to 58.8 K (-7.10 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Buy | M | 0.64 | 10,000 | 6,380 | 78,736 | 68.7 K to 78.7 K (+14.55 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 9.85 | 220 | 2,167 | 36,255 | 36.5 K to 36.3 K (-0.60 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 10.50 | 400 | 4,200 | 767,418 | 767 K to 767.4 K (+0.05 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 10.37 | 300 | 3,111 | 767,018 | 766.7 K to 767 K (+0.04 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 10.31 | 100 | 1,031 | 766,718 | 766.6 K to 766.7 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 10.03 | 100 | 1,003 | 766,618 | 766.5 K to 766.6 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.96 | 200 | 1,992 | 766,518 | 766.3 K to 766.5 K (+0.03 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.95 | 100 | 995 | 766,318 | 766.2 K to 766.3 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.87 | 100 | 987 | 766,218 | 766.1 K to 766.2 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.86 | 115 | 1,134 | 766,118 | 766 K to 766.1 K (+0.02 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.85 | 3,337 | 32,869 | 766,003 | 762.7 K to 766 K (+0.44 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.85 | 300 | 2,954 | 762,666 | 762.4 K to 762.7 K (+0.04 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.84 | 100 | 984 | 762,366 | 762.3 K to 762.4 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.84 | 100 | 984 | 762,266 | 762.2 K to 762.3 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.84 | 100 | 984 | 762,166 | 762.1 K to 762.2 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.84 | 100 | 984 | 762,066 | 762 K to 762.1 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.82 | 800 | 7,856 | 761,966 | 761.2 K to 762 K (+0.11 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.82 | 100 | 982 | 761,166 | 761.1 K to 761.2 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.81 | 400 | 3,924 | 761,066 | 760.7 K to 761.1 K (+0.05 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.80 | 885 | 8,673 | 760,666 | 759.8 K to 760.7 K (+0.12 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.79 | 100 | 979 | 759,781 | 759.7 K to 759.8 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.77 | 100 | 977 | 759,681 | 759.6 K to 759.7 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.76 | 100 | 976 | 759,581 | 759.5 K to 759.6 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.73 | 200 | 1,946 | 759,481 | 759.3 K to 759.5 K (+0.03 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.72 | 100 | 972 | 759,281 | 759.2 K to 759.3 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.70 | 100 | 970 | 759,181 | 759.1 K to 759.2 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.64 | 100 | 964 | 759,081 | 759 K to 759.1 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 9.63 | 200 | 1,926 | 758,981 | 758.8 K to 759 K (+0.03 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 10.50 | 400 | 4,200 | 767,418 | 767 K to 767.4 K (+0.05 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 10.37 | 300 | 3,111 | 767,018 | 766.7 K to 767 K (+0.04 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 10.31 | 100 | 1,031 | 766,718 | 766.6 K to 766.7 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 10.03 | 100 | 1,003 | 766,618 | 766.5 K to 766.6 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.96 | 200 | 1,992 | 766,518 | 766.3 K to 766.5 K (+0.03 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.95 | 100 | 995 | 766,318 | 766.2 K to 766.3 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.87 | 100 | 987 | 766,218 | 766.1 K to 766.2 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.86 | 115 | 1,134 | 766,118 | 766 K to 766.1 K (+0.02 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.85 | 3,337 | 32,869 | 766,003 | 762.7 K to 766 K (+0.44 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.85 | 300 | 2,954 | 762,666 | 762.4 K to 762.7 K (+0.04 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.84 | 100 | 984 | 762,366 | 762.3 K to 762.4 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.84 | 100 | 984 | 762,266 | 762.2 K to 762.3 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.84 | 100 | 984 | 762,166 | 762.1 K to 762.2 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.84 | 100 | 984 | 762,066 | 762 K to 762.1 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.82 | 800 | 7,856 | 761,966 | 761.2 K to 762 K (+0.11 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.82 | 100 | 982 | 761,166 | 761.1 K to 761.2 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.81 | 400 | 3,924 | 761,066 | 760.7 K to 761.1 K (+0.05 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.80 | 885 | 8,673 | 760,666 | 759.8 K to 760.7 K (+0.12 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.79 | 100 | 979 | 759,781 | 759.7 K to 759.8 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.77 | 100 | 977 | 759,681 | 759.6 K to 759.7 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.76 | 100 | 976 | 759,581 | 759.5 K to 759.6 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.73 | 200 | 1,946 | 759,481 | 759.3 K to 759.5 K (+0.03 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.72 | 100 | 972 | 759,281 | 759.2 K to 759.3 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.70 | 100 | 970 | 759,181 | 759.1 K to 759.2 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.64 | 100 | 964 | 759,081 | 759 K to 759.1 K (+0.01 %) |
Mar 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Buy | P | 9.63 | 200 | 1,926 | 758,981 | 758.8 K to 759 K (+0.03 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Drug Dev ... | Sell | S | 10.55 | 100 | 1,055 | 43,366 | 43.5 K to 43.4 K (-0.23 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Drug Dev ... | Sell | S | 10.54 | 100 | 1,054 | 43,466 | 43.6 K to 43.5 K (-0.23 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Drug Dev ... | Sell | S | 10.53 | 900 | 9,477 | 43,566 | 44.5 K to 43.6 K (-2.02 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Drug Dev ... | Sell | S | 10.50 | 139 | 1,460 | 44,466 | 44.6 K to 44.5 K (-0.31 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Drug Dev ... | Sell | S | 10.49 | 200 | 2,098 | 44,605 | 44.8 K to 44.6 K (-0.45 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Drug Dev ... | Sell | S | 10.47 | 561 | 5,874 | 44,805 | 45.4 K to 44.8 K (-1.24 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Drug Dev ... | Sell | S | 10.46 | 500 | 5,230 | 45,366 | 45.9 K to 45.4 K (-1.09 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Sell | S | 10.10 | 6 | 61 | 152 | 158 to 152 (-3.80 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Sell | S | 10.08 | 18 | 181 | 158 | 176 to 158 (-10.23 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Sell | S | 10.07 | 100 | 1,007 | 176 | 276 to 176 (-36.23 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Sell | S | 10.06 | 100 | 1,006 | 276 | 376 to 276 (-26.60 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Sell | S | 10.05 | 900 | 9,045 | 376 | 1.3 K to 376 (-70.53 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Sell | S | 10.04 | 910 | 9,136 | 1,276 | 2.2 K to 1.3 K (-41.63 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Sell | S | 10.03 | 462 | 4,634 | 2,186 | 2.6 K to 2.2 K (-17.45 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Sell | S | 10.03 | 100 | 1,003 | 2,648 | 2.7 K to 2.6 K (-3.64 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Sell | S | 10.02 | 333 | 3,337 | 2,748 | 3.1 K to 2.7 K (-10.81 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Sell | S | 10.01 | 1,700 | 17,017 | 3,081 | 4.8 K to 3.1 K (-35.56 %) |
Mar 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Sell | S | 10.00 | 5,371 | 53,710 | 4,781 | 10.2 K to 4.8 K (-52.91 %) |
Feb 28 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 10.05 | 500 | 5,025 | 758,781 | 758.3 K to 758.8 K (+0.07 %) |
Feb 28 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 10.49 | 400 | 4,196 | 758,281 | 757.9 K to 758.3 K (+0.05 %) |
Feb 28 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 10.16 | 100 | 1,016 | 757,881 | 757.8 K to 757.9 K (+0.01 %) |
Feb 28 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 10.15 | 200 | 2,030 | 757,781 | 757.6 K to 757.8 K (+0.03 %) |
Feb 28 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 10.14 | 100 | 1,014 | 757,581 | 757.5 K to 757.6 K (+0.01 %) |
Feb 28 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 10.13 | 77 | 780 | 757,481 | 757.4 K to 757.5 K (+0.01 %) |
Feb 28 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 10.12 | 123 | 1,245 | 757,404 | 757.3 K to 757.4 K (+0.02 %) |
Feb 28 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 10.10 | 179 | 1,808 | 757,281 | 757.1 K to 757.3 K (+0.02 %) |
Feb 28 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 10.09 | 421 | 4,248 | 757,102 | 756.7 K to 757.1 K (+0.06 %) |
Feb 28 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 10.06 | 100 | 1,006 | 756,681 | 756.6 K to 756.7 K (+0.01 %) |
Feb 28 2008 | FOLD | AMICUS THERAPEUTIC ... | FHM IV LP | 10% Owner | Buy | P | 10.05 | 900 | 9,045 | 756,581 | 755.7 K to 756.6 K (+0.12 %) |